Bill Gates &MG Foundation &BIOTRON, page-175

There are hundreds and hundreds of HIV drugs in clinical trials.

If BIT225 was as good as you think it is, a big pharma would likely have already bitten. As I have posted previously, big pharma have entered into many early stage collaborations with biotech companies (i.e. well before phase 2) when they think the product is promising enough.

Without a deal, the reality is we will not be able to progress to Phase 3 trials. At this stage, no one seems interested.

I also note you were originally extremely bullish on the science surrounding BIT225 and HCV as you can see in your post by clicking hereor here or here. You felt the product was too good! History shows this did not pan out.

As i keep repeating, the vast majority of candidate drugs will sadly fail.